INTRODUCTION: The value of extensive tumor resection in pediatric brain tumours is well known. Image-guided surgery can help to achieve maximal safe resections. We analyze our experience with low-field PoleStar N20 iMR system in 17 pediatric patients, focusing on its feasibility in this population, its usefulness, and its accordance with the early postoperative high-field MR study. MATERIAL AND METHODS: Seventeen iMR-guided procedures were performed between 2011 and 2016. Children were between 8 months and 16 years old. Patientś head was fixed in a MR-compatible head-clamp or positioned on a plastic headrest depending on the age. Prone, supine or lateral positioning was chosen depending on tumor location. After resection iMR images were acquired to detect residual tumour. Early 3-T postoperative MR scan were obtained in all cases and compared to intraoperative low-field images. RESULTS: Patient positioning resulted easier than in adults due to their smaller size. iMR surgery took extra time for setup and scanning (between 15-175 min, mean 110min). In six cases, intraoperative images showed residual tumor and surgery was continued until complete resection was verified in a new scan. Complete resection was achieved in 15 cases (88.23%). We had neither intraoperative adverse events nor craniotomy infections related to the use of this equipment. There was a good correlation between Polestar images and high field 3-T postoperative control images. CONCLUSION: The Polestar N20 iMR is feasible and safe as an adjunct for pediatric brain tumor resection. It provides enough quality images to detect residual tumor and update neuronavigation.
. 2016 May 30;18(Suppl 3):iii129. doi: 10.1093/neuonc/now078.11
NS-11: LOW-FIELD POLESTAR N20 MOBILE iMR SYSTEM AS AN ADJUNCT FOR PEDIATRIC BRAIN TUMOR RESECTION: FEASIBILITY, USEFULNESS AND SAFETY
Salinas Sanz Jose Antonio
1, Brell Doval Marta
2, Ibañez Dominguez Javier
2, Guibelalde del Castillo Mercedes
1, Rocabado Quintana Sergio Alejandro
2, Roldan Busto Jordi
3, Hernandez Bernal Maria Isabel
1, Ferres Ramis Laia
1
Salinas Sanz Jose Antonio
1Pediatric Oncology Department. Son Espases Hospital, Palma de Mallorca, Spain
Find articles by Salinas Sanz Jose Antonio
Brell Doval Marta
2Neurosurgery Department. Son Espases Hospital, Palma de Mallorca, Spain
Find articles by Brell Doval Marta
Ibañez Dominguez Javier
2Neurosurgery Department. Son Espases Hospital, Palma de Mallorca, Spain
Find articles by Ibañez Dominguez Javier
Guibelalde del Castillo Mercedes
1Pediatric Oncology Department. Son Espases Hospital, Palma de Mallorca, Spain
Find articles by Guibelalde del Castillo Mercedes
Rocabado Quintana Sergio Alejandro
2Neurosurgery Department. Son Espases Hospital, Palma de Mallorca, Spain
Find articles by Rocabado Quintana Sergio Alejandro
Roldan Busto Jordi
3Radiology Department. Son Espases Hospital, Palma de Mallorca, Spain
Find articles by Roldan Busto Jordi
Hernandez Bernal Maria Isabel
1Pediatric Oncology Department. Son Espases Hospital, Palma de Mallorca, Spain
Find articles by Hernandez Bernal Maria Isabel
Ferres Ramis Laia
1Pediatric Oncology Department. Son Espases Hospital, Palma de Mallorca, Spain
Find articles by Ferres Ramis Laia
1Pediatric Oncology Department. Son Espases Hospital, Palma de Mallorca, Spain
2Neurosurgery Department. Son Espases Hospital, Palma de Mallorca, Spain
3Radiology Department. Son Espases Hospital, Palma de Mallorca, Spain
Issue date 2016 Jun.
© the author(s) 2016. published by oxford university press on behalf of the society for neuro-oncology. all rights reserved. for permissions, please e-mail: journals.permissions@oup.com
PMCID: PMC4903686
